Evidence map›Paper›PMID 30536931›Full record

ArticlePacing and clinical electrophysiology : PACE2019

Remote monitoring of implantable cardioverter defibrillators: Patient experiences and preferences for follow-up.

Ivy Timmermans, Mathias Meine, Istvan Szendey, Johannes Aring, Javier Romero Roldán, Lieselotte van Erven, Philipp Kahlert, Edgar Zitron, Philippe Mabo, Johan Denollet and 1 more

Abstract read
In one paragraph

Article in Pacing and clinical electrophysiology : PACE, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Effect of remote monitoring on clinical outcomes in European heart failure patients with an implantable cardioverter-defibrillator: secondary results of the REMOTE-CIED randomized trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022
    Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Remote monitoring in implantable cardiac devices: A care solution or alert pollution?Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. 2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  20. New insertable cardiac monitors show high diagnostic yield and good safety profile in real-world clinical practice: results from the international prospective observational SMART Registry.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Ivy TimmermansDepartment of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID 0000-0003-4965-1683
Mathias MeineDepartment of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Istvan SzendeyDepartment of Cardiology, Kliniken Maria Hilf GmbH, Mönchengladbach, Germany.
Johannes AringDepartment of Cardiology, Klinikum Leverkusen, Leverkusen, Germany.
Javier Romero RoldánDepartment of Cardiology, Complejo Hospitalario de Navarra, Pamplona, Spain.
Lieselotte van ErvenDepartment of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
Philipp KahlertWest German Heart and Vascular Center Essen, Essen University Hospital, Essen, Germany.
Edgar ZitronDepartment of Cardiology, Universitätsklinikum Heidelberg, Heidelberg, Germany.
Philippe MaboDepartment of Cardiology, Centre Hospitalier Universitaire Rennes, Rennes, France.
Johan DenolletCoRPS-Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands.
Henneke VersteegDepartment of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Funding

Boston Scientific Corporation research grant to support independent investigator
6 · The paper itself

Abstract

backgroundPatient satisfaction with remote patient monitoring (RPM) of implantable cardioverter defibrillators (ICDs) seems to be high, yet knowledge on long-term patient experiences is limited. The European REMOTE-CIED study explored patients' experiences with RPM, examined patient's preferences for ICD follow-up, and identified determinants of patient's preferences in the first 2 years postimplantation.

methodsEuropean heart failure patients (N = 300; median age = 66 years [interquartile range (IQR) = 59-73], and 22% female) with a first-time ICD received a Boston Scientific LATITUDE RPM system (Marlborough, MA, USA) and had scheduled in-clinic follow-ups once a year. Patients completed questionnaires at 1-2 weeks and also at 3, 6, 12, and 24 months postimplantation and clinical data were obtained from their medical records. Patient evaluation data were analyzed descriptively, and Student's t-tests/Man-Whitney U tests or Chi-square tests/Fisher's exact tests were performed to examine determinants of patient preferences.

resultsAt 2 years postimplantation, the median patient satisfaction score with the RPM system was 9 out of 10 (IQR = 8-10), despite 53% of the patients experiencing issues (eg, failure to transmit data). Of the 221 patients who reported their follow-up preferences, 43% preferred RPM and 19% preferred in-clinic follow-up. Patients with a preference for RPM were more likely to be higher educated (P = 0.04), employed (P = 0.04), and equipped with a new LATITUDE model (P = 0.04), but less likely to suffer from chronic obstructive pulmonary disease (P = 0.009).

conclusionIn general, patients were highly satisfied with RPM, but a subgroup preferred in-clinic follow-up. Therefore, physicians should include patients' concerns and preferences in the decision-making process, to tailor device follow-up to individual patients' needs and preferences.

Indexed as

Defibrillators, ImplantablePatient SatisfactionTelemedicineAgedFemaleFollow-Up StudiesHeart FailureHumansMaleMiddle AgedMonitoring, PhysiologicPatient PreferenceSelf ReportSurveys and Questionnairesimplantable cardioverter defibrillatorpatient experiencespatient preferencesremote patient monitoring

Identifiers

PMID30536931
PMCPMC6849564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.